Agenda

Theme: 80% of the 38,000 adults over 50 surveyed in the 2010 AARP Member Opinion Survey indicated “Staying Mentally Sharp”  as their top ranked interest and concern. This consumer-fueled interest, combined with growing research on lifelong neuroplasticity and the cognitive reserve and with a growing marketplace of “brain fitness” products and services, constitutes a call to action to expand the brain health toolkit to meet growing needs across the lifespan. Intel CEO Paul Otellini is quoted as saying, “You have to start by thinking about what people want to do…and work backward,” and the 2011 SharpBrains Summit: Retooling Brain Health for the 21st Century will do so by showcasing the latest trends taking place among consumers and professionals, in industry, research, technology, and care, to identify critical opportunities and challenges to develop a valuable  innovation ecosystem which may exceed $2B worldwide in 2015.


–>Reg­is­tered Sum­mit par­tic­i­pants can access all Ses­sion Record­ings until Sep­tem­ber 30th, 2012 by click­ing on the ses­sion titles below and log­ging in using the same User­name and Pass­word they used to access the Summit. 

–>Did­n’t Reg­is­ter but want to access all Ses­sion Record­ings? Click Here to Learn How.

Wednesday, March 30th, 2011

Market Insights

Thursday, March 31st, 2011

R&D Insights

Friday, April 1st, 2011

Expo Day
7.30am: 2011 Sharp­Brains Vir­tu­al Sum­mit opens for reg­is­tered par­tic­i­pants.8.15am: Wel­come Remarks by Dr. Bren­da Dann-Messier, Assis­tant Sec­re­tary for Voca­tion­al and Adult Edu­ca­tion, US Depart­ment of Edu­ca­tion.8.30–10am: The Inno­va­tion Imper­a­tive: Meet­ing Grow­ing Demands at Low­er Costs. Call it “brain fit­ness” or “men­tal cap­i­tal”, there is clear inter­est world­wide in how non-inva­sive tech­nolo­gies and lifestyle approach­es can help main­tain brain health and per­for­mance across the lifes­pan, paving the way for a grow­ing inno­va­tion ecosys­tem that can sig­nif­i­cant­ly impact aca­d­e­m­ic and work­place per­for­mance, clin­i­cal out­comes and qual­i­ty of life. What is dri­ving inno­va­tion, and how can we best har­ness growth to deliv­er value?
  • Dr. Ken­neth Kosik, Direc­tor, UCSB Neu­ro­science Insti­tute, and Founder, CFIT
  • Dr. Cary Coop­er, Sci­ence Coor­di­na­tor, Fore­sight Project on Men­tal Cap­i­tal and Wellbeing
  • Dr. Kei­th Wesnes, Prac­tice Leader, Unit­ed BioSource
  • Nigel Smith, Inno­va­tion Direc­tor, AARP
  • Mod­er­at­ed by: Dr. James Gior­dano, Direc­tor of the Cen­ter for Neu­rotech­nol­o­gy Stud­ies, Potomac Insti­tute for Pol­i­cy Studies

10.15–11.45am: Antic­i­pat­ing Future Demands of Savvy Con­sumers. What are people’s pri­or­i­ties, beliefs and habits in terms of how to main­tain cog­ni­tive and emo­tion­al health and per­for­mance? What evolv­ing choic­es will con­sumers and the pro­fes­sion­als serv­ing them face in the future? How will new tools be inte­grat­ed into exist­ing settings?

  • Lind­say Gask­ins, CEO, Mar­bles: the Brain Store
  • Robin Klaus, Chair­man, Club One
  • Dr. Hen­ry Mah­ncke, CEO, Posit Science
  • Dr. Peter Rein­er, Co-Founder Nation­al Core for Neu­roethics, Uni­ver­sity of British Columbia
  • Mar­garet Mor­ris, Senior Researcher, Intel’s Dig­i­tal Health Group
  • Mod­er­at­ed by: Alexan­dra More­house, CMO at AAA North California

1–2pm: Pro­tect­ing and Devel­op­ing Young Minds. The acqui­si­tion of Cogmed by Pear­son in June 2010 could prove to be a land­mark in refram­ing edu­ca­tion, spe­cial edu­ca­tion and cog­ni­tive reha­bil­i­ta­tion into per­son­al­ized and tar­get­ed capac­i­ty-build­ing inter­ven­tions. How can brain-based bot­tle­necks be iden­ti­fied and addressed ear­ly on? How will inno­v­a­tive inter­ven­tions be delivered?

  • Jonas Jen­di, CEO, Cogmed
  • Dr. Tra­cy Alloway, Direc­tor Cen­ter Mem­ory & Learn­ing, Uni­v. Stirling
  • Ken Gib­son, Pres­i­dent, LearningRx
  • Mod­er­at­ed by: Alvaro Fer­nan­dez, CEO, SharpBrains

2.15–2.45pm: A Work­place Health & Pro­duc­tiv­i­ty Case Study — From Lab to Roll­out. The mar­ket for employ­er-dri­ven solu­tions to mon­i­tor and enhance cog­ni­tion and well­ness is gain­ing trac­tion with a dual health & pro­duc­tiv­i­ty val­ue propo­si­tion. What are employ­ers look­ing for in these ser­vices? How can insur­ers cap­i­tal­ize on the oppor­tu­ni­ty via option­al assis­tance prod­ucts pro­vid­ed through health insur­ance pack­ages? How will these emerg­ing capa­bil­i­ties impact the tra­di­tion­al prac­tices of Human Resources departments?

  • Evian Gor­don, CEO, Brain Resource
  • Kath­leen Herath, Asst Vice Pres­i­dent, Nation­wide Insurance
  • Mod­er­at­ed by: Pat­ty Pur­pur, Direc­tor, Stan­ford Health Pro­mo­tion Network

3–4.30pm: Cog­ni­tive Ser­vices for Active Aging — What a Brain Gym Looks Like. Adults over 50 in North Amer­i­ca are adopt­ing “brain fit­ness” as a main­stream lifestyle choice, and emerg­ing ser­vice-based mod­els are help­ing them nav­i­gate options to pro­mote active aging. What qual­i­ty of life out­comes and busi­ness dri­vers jus­ti­fy such efforts? What are the chal­lenges to devel­op, mar­ket and scale inno­v­a­tive programs?

  • Lena Perel­man, Direc­tor Com­mu­nity Out­reach, SCAN Health Plan
  • Bev­erly San­born, Vice Pres­i­dent of Activ­i­ties and Mem­ory Pro­grams, Bel­mont Vil­lage Senior Living
  • Lisa Schooner­man, Co-Founder, VibrantBrains
  • Dr. Dhar­ma Singh Khal­sa, Pres­i­dent, Alzheimer’s Research and Pre­ven­tion Foundation
  • Mod­er­at­ed by: Dr. David Tal, Direc­tor, A.G.E. Mat­ters Clinic


 7.30–8am: The NIH Tool­box for Assess­ment of Neu­ro­log­i­cal and Behav­ioral Func­tion. Dr. Mol­ly Wag­ster, Chief, Behav­ioral and Sys­tems Neu­ro­science Branch at the Nation­al Insti­tute of Aging (NIA).8–8.30am: Past, Present and Future of Applied Neu­ro­plas­tic­i­ty.Dr. Michael Merzenich, Emer­i­tus Pro­fes­sor at UC-San Fran­cis­co.8.45–10am: The Role of Cog­ni­tive Health Mon­i­tor­ing Sys­tems. A miss­ing piece in today’s brain health toolk­it is the capa­bil­i­ty to mon­i­tor a person’s cog­ni­tive per­for­mance and Cog­ni­tive Reserve across the lifes­pan. Such a sys­tem could great­ly facil­i­tate the pre­ven­tion, diag­no­sis and treat­ment of cog­ni­tive decline due to aging and dis­ease. Pol­i­cy, research and tech­nol­o­gy strands are con­verg­ing to bet­ter define and meet this need: Which instru­ments, plat­forms and ana­lyt­i­cal approach­es could pro­vide the data and out­comes required? How will behav­ioral mark­ers com­ple­ment bio­log­i­cal and neu­roimag­ing mark­ers? How may cog­ni­tive mon­i­tor­ing sys­tems be devel­oped, mar­ket­ed and used?
  • Dr. Yaakov Stern, Head Cog­ni­tive Neu­ro­science Divi­sion of the Taub Insti­tute, Colum­bia University
  • Dr. David Dar­by, Chief Med­ical Offi­cer, CogState
  • Dr. Jef­frey Kaye, Direc­tor, NIA — ORCATECH
  • Mod­er­at­ed by: Dr. Joshua Stein­er­man, Assis­tant Pro­fes­sor, Albert Ein­stein Col­lege of Medicine

10.15–11.30am: The Busi­ness Case — Scal­ing up Cost-effi­cient Sys­tems to Extend Well­ness and Mod­u­lat­e Risks. The deliv­ery of cog­ni­tive inter­ven­tions is often restrict­ed  by the expen­sive and time-inten­sive nature of the inter­ven­tion and the lack of enough skilled prac­ti­tion­ers. Tech­nol­o­gy assist­ed ther­a­pies and train­ing have the poten­tial to alle­vi­ate this bot­tle­neck, reach­ing beyond tra­di­tion­al client/ patient groups. How will inter­ven­tions tar­get iden­ti­fied needs? Do reim­burse­ment poli­cies need to be updat­ed? How will large data sets be used to ben­e­fit both the end-user and the providers?

  • Tom War­den, Vice Pres­i­dent, Allstate
  • Dr. Justin Mar­ley, Chair Men­tal Health Infor­mat­ics Group, UK Roy­al Col­lege of Psychiatrists
  • Dr. Joe Hardy, Senior Direc­tor R&D, Lumos Labs
  • Mod­er­at­ed by: Veroni­ka Litin­s­ki, Advi­sor, MaRS Life Sci­ences and Health Care

12.45–2pm: Beyond the Con­tro­ver­sy: Defin­ing “Brain Train­ing” and Its Appli­ca­tions. As evi­denced by the “BBC brain train­ing exper­i­ment”, sig­nif­i­cant con­tro­ver­sy has been brew­ing around what “brain train­ing” is and what spe­cif­ic appli­ca­tions war­rant it. This pan­el will dis­cuss research-backed method­olo­gies and ana­lyze the key “con­di­tions for trans­fer” to real-world ben­e­fits, match­ing pop­u­la­tion, need, and inter­ven­tion pro­to­col and dura­tion. Is there a way to stan­dard­ize inter­ven­tions to dri­ve bet­ter research and inform both preventive/ clin­i­cal care and con­sumer decisión-making?

  • Dr. Daphne Bave­lier, Direc­tor Brain and Vision Lab, Uni­v. Rochester
  • Dr. Jer­ri Edwards, Asso­ciate Pro­fes­sor, USF
  • Dr. Adam Gaz­za­ley, Direc­tor Neu­ro­science Imag­ing Cen­ter, UCSF
  • Dr. Sophia Vino­gradov, Inter­im Vice Chair Psy­chi­a­try, UCSF
  • Mod­er­at­ed by: Dr. Jamie Wil­son, Plat­form Direc­tor, SharpBrains

2.15–2.45pm: The State of Inno­va­tion and Emerg­ing Mar­ket­place. While healthy aging is the most vis­i­ble dri­ver of growth today, ear­ly adopters are also embrac­ing inter­ven­tions that enhance brain per­for­mance across the lifes­pan. What part­ner­ships and alliances will be required to align main­stream inter­est with val­i­dat­ed research, and posi­tion scal­able tools with­in a coher­ent and sus­tain­able mar­ket­place? Sharp­Brains fore­casts the world­wide mar­ket to exceed $2 bil­lion by 2015 depend­ing on how impor­tant cat­e­go­ry bot­tle­necks are addressed.

  • Alvaro Fer­nan­dez, CEO, SharpBrains
  • Mod­er­at­ed by: Muki Hansteen-Izo­ra, Senior Design Researcher and Strate­gist, Intel’s Dig­i­tal Health Group

3–4.30pm: What’s Next — Stan­dard­iz­ing Out­comes to Dri­ve Valu­able Inno­va­tion. Can eat­ing cere­al brain X make your kids smarter? what about aer­o­bic exer­cise, or play­ing the piano? Does play­ing videogame Y enhance work­ing mem­o­ry – or con­tribute to deplete it? Are “smart pills” real­ly here or around the cor­ner? Do sup­ple­ments improve mem­o­ry and brain­pow­er? Frag­men­tary news cov­er­age around many of these ques­tions com­bined with aggres­sive mar­ket­ing claims present the chal­lenge of how to best nav­i­gate options – which will only be pos­si­ble when we can com­pare “apples with apples” out­comes. How can inter­est­ed par­ties, from con­sumers to pol­i­cy-mak­ers, make sense of the land­scape today?

  • Dr. Gary Small, Direc­tor Cen­ter on Aging, UCLA
  • Dr. Michael Valen­zuela, Leader Regen­er­a­tive Neu­ro­science Group, Uni­ver­si­ty of New South Wales
  • Dr. Martha Farah, Direc­tor Cen­ter for Neu­ro­science and Soci­ety, UPenn
  • Dr. Bill Reich­man, CEO, Baycrest
  • Mod­er­at­ed by: Paula Psyl­lakis, Senior Pol­i­cy Advi­sor, Ontario Min­istry of Research and Innovation
 8.30–9.30am: From Lab to Mar­ket­place: How Sci­ence Reach­es Users. Tech­nol­o­gy trans­fer from the lab to lead users is fraught with chal­lenges, espe­cial­ly in new cat­e­gories which lack estab­lished stan­dards, chan­nels, and investor inter­est. What com­mer­cial­iza­tion paths, busi­ness mod­els and invest­ment sce­nar­ios will bet­ter allow for the need­ed pool­ing of sci­en­tif­ic, entre­pre­neur­ial and invest­ment resources to com­mer­cial­ize non-inva­sive appli­ca­tions of cog­ni­tive and affec­tive neu­ro­science? What are ear­ly-adopters such as Wal­ter Reed Army Med­ical Cen­ter doing and look­ing for?
  • Dr. Wal­ter Green­leaf, CEO, Vir­tu­al­ly Better
  • Kate Sul­li­van, Direc­tor Brain Fit­ness Cen­ter, Wal­ter Reed Army Med­ical Center
  • Mod­er­at­ed by: Dr. John Rep­pas, Pol­i­cy Direc­tor, Neu­rotech­nol­o­gy Indus­try Organization

10–10.30am: Lumos Labs presentation/ demo

10.45–11.15am: Brain Resource presentation/ demo

11.30am-Noon: Cogmed presentation/ demo

1–1.30pm: Bay­crest presentation/ demo

1.45–2.15pm: Cog­niFit presentation/ demo

Leave a Reply